RM Global Health

www.rmgh.net

 
  • Increase font size
  • Default font size
  • Decrease font size
  • default color
  • green color
  • blue color

Quest Diagnostics Declares Quarterly Cash Dividend

Sunday, 17 February 2008 01:50 Ramaz Mitaishvili
E-mail Print PDF
MADISON, N.J., Feb. 14 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend on Quest Diagnostics common stock of $0.10 per share, payable on April 18, 2008, to shareholders of record on April 4, 2008.

About Quest Diagnostics

Quest Diagnostics is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at: >>

SOURCE Quest Diagnostics Incorporated

CONTACT: Investors, Laure Park, +1-973-520-2900,
Media, Nancy Fitzsimmons,
+1-973-520-2800,
both of Quest Diagnostics Incorporated

 
Malaria
Malaria Awareness
Malaria kills more than 1 million people each year. Most are young children in sub-Saharan Africa. "Free Africa from Malaria Now" is the theme of Africa Malaria Day, April 25, which this year marks also the first US Malaria Awareness Day.

Alerts

Can Pharmacists Improve the Accuracy of Medication Histories? Can Pharmacists Improve the Accuracy of Medication Histories? Reviewed by Ramaz Mitaishvili, MD 
 
Byetta Linked to Acute Pancreatitis Six new cases of hemorrhagic or necrotizing pancreatitis have been reported in patients using exenatide injection (Byett...
 
Why Should I Report an Adverse Drug Event? When I was in charge of the postmarketing drug safety program at the US Food and Drug Administration (FDA) in the early ...